Amy Sinor-Anderson

Amy Sinor-Anderson is a seasoned professional in scientific communication and medical affairs with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director of Scientific Communication at Denali Therapeutics since November 2024, Amy previously held senior leadership roles at GRAIL, Inc., and EMD Serono, Inc., where significant achievements include receiving multiple Presidents Awards for collaborative efforts and successful product launch strategies. Earlier in Amy’s career, positions at GE Healthcare, Thermo Fisher Scientific, and Curis contributed to a robust foundation in research and product development. Academic qualifications include a PhD in Neurobiology from the University of Pittsburgh School of Medicine and a BA in Biology and Chemistry from Skidmore College.